CSIMarket
 
Pharma-Bio Serv, Inc.  (OTC: PBSV)
    Sector • Services    Industry • Consulting Services
   Industry • Consulting Services
   Sector • Services
 

Pharma-bio Serv's Customers Performance

PBSV



 
PBSV's Source of Revenues During the corresponding time, Pharma-bio Serv, Inc. recorded a revenue increase by 19 % year on year, sequentially revenue fell by -13.57 %. While revenue at the Pharma-bio Serv, Inc.'s corporate clients

• List of PBSV Customers




for the same period Pharma-bio Serv, Inc. recorded revenue increase by 19 % year on year, sequentially revenue fell by -13.57 %.

• List of PBSV Customers

Pharma-bio Serv's Business Units
Puerto Rico Consulting    170.51 % of total Revenue
United States Consulting    81.64 % of total Revenue
Europe Consulting    61.56 % of total Revenue
Other Segment    0.3 % of total Revenue






Pharma-bio Serv's Comment on Sales, Marketing and Customers



The company had three principal customers, each accounting for 10% or more of revenues in the years ended October 31, 2025 and 2024, collectively representing 43.5% and 44.2% of total revenue, respectively. Its services are typically project-based, resulting in a regularly changing client base. The company operates in a highly competitive and fragmented industry, competing with regional, national, and international firms, including local competitors with potentially greater resources. It has over 30 years of market presence in Puerto Rico and maintains relationships with major pharmaceutical, biotechnology, medical device, and chemical manufacturing companies. The market for qualified technical consultants is competitive and includes competitors as well as companies in the pharmaceutical, chemical, biotechnology, and medical device sectors that are clients or potential clients. The company leverages its name recognition in Puerto Rico, reputation, and salary and benefit packages to attract qualified personnel.





Pharma-bio Serv’s Comment on Sales, Marketing and Customers


The company had three principal customers, each accounting for 10% or more of revenues in the years ended October 31, 2025 and 2024, collectively representing 43.5% and 44.2% of total revenue, respectively. Its services are typically project-based, resulting in a regularly changing client base. The company operates in a highly competitive and fragmented industry, competing with regional, national, and international firms, including local competitors with potentially greater resources. It has over 30 years of market presence in Puerto Rico and maintains relationships with major pharmaceutical, biotechnology, medical device, and chemical manufacturing companies. The market for qualified technical consultants is competitive and includes competitors as well as companies in the pharmaceutical, chemical, biotechnology, and medical device sectors that are clients or potential clients. The company leverages its name recognition in Puerto Rico, reputation, and salary and benefit packages to attract qualified personnel.








PBSV's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Pharma-Bio Serv, Inc. 12.60 9.48 0.11 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Pharma-Bio Serv, Inc.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pharma-Bio Serv, Inc.’s corporate clients.
For your research, we’ve provided 9 tables on Pharma-Bio Serv, Inc. corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.